Try our Advanced Search for more refined results
Health - January, 2008
175 articles
- Judge Corrects Claim Order In Medtronic Stent Case
- $1B Deal On Zyprexa Still May Not End Lilly's Woes
- Wyeth Victory In Prempro Lawsuit Survives Appeal
- Professor Raises Antitrust Issue In Vioxx Agreement
- Benefits Of ADEA Exemption Rule
- Lawyers In Guidant MDL Spar Over $45M Fee Request
- Chinese Producer Of Abortion Pill Under Investigation
- Crowell & Moring Nets Ex-FTC Attorney
- FDA Chastises Novartis Unit Over Safety Issues
- Sonnenschein Lures Litigator From Locke Lord
- Criminal Prosecution Of Off-Label Drug Promotion
- Hernia Patch Plaintiffs Play Hardball Over Names
- Wyeth Launches Generic Protonix To Preempt Rivals
- Floridians Wrongly Shut Out Of Vioxx Deal: Lawyers
- Nigerian Case Against Pfizer Runs Into Delay
- Patent Case V. Stryker Has Merit: Federal Circuit
- Fosamax Judge Tosses Leftover Class Action Claims
- Upsher-Smith's ANDA Spurs Another Suit From Forest
- MSJ Based On Motor Carrier FLSA Exemption Fails
- Bausch & Lomb ReNu Tests Were Flawed: Study
- Calif. Brings $1.6B Suit Against UnitedHealth
- Synthes Knowingly Sold Faulty Bone Implants: Suit
- States To Investigate Vytorin Marketing Ploys
- Lawmakers Subpoena FDA, HHS Head In Ketec Probe
- FDA Must Step Up Medical Device Scrutiny: GAO
- Court Nixes J&J's Bid To Toss Stent Patent Suits
- AARP, FTC File Amicus Briefs In Cipro Case
- Product Safety Initiative Should Go Global: FDA
- Impax's ANDA For Generic Painkiller Spurs Suit
- Baxter Recalls Heparin Doses
- Cordis Yanks Catheters Over Potentially Fatal Flaw
- Plaintiffs Push For Trial Date In AWP Lawsuit
- Glaxo Won't Block Generic Of Zantac Syrup
- Allergan Punches Back At Botox Death Claims
- Forest Labs Sues Six More Companies Over Namenda
- Apotex Gets $5M In Ear-Drop Patent Suit
- Plaintiffs Scoff At Pfizer's Experts On Viagra Safety
- Bayer Recalls Liquid Leukine For Adverse Effects
- Physician Arrangements Get Device Makers In Trouble
- Unauthorized Work Is Still Work: 2nd Circ.
- As FDA Review Looms, Drug Cos. Defend Vytorin Study
- $6.6M Awarded To Oculus In Trade Secret Suit
- PTO Rejects Gilead's Patents For HIV Drug
- Seroquel Plaintiffs Move To Quiz AstraZeneca's Drs.
- Vendors, Law Firms Clash Over E-Discovery
- FDA Removes Teeth From Exclusivity Forfeiture
- District Court Dismisses Tyco Antitrust Suit
- Lawmakers Urge FDA To Rethink Drug Labeling
- Mylan Hit With $69.2M In Treble Damages
- Lawmaker Wants Details On Rule For Drug Marketing
- Study Links Nexavar To Hypertension Risk
- Pregnant Pause In Barr-J&J Contraceptive Dispute
- J&J Battles Consolidation Of Ortho-Evra Lawsuits
- Merck, Schering Suspend TV Ads Touting Vytorin
- Judge Nixes Doctor Chats In Hernia Patch Case
- Home Care Co. Hit With Wage-And-Hour Suit
- Lawmakers Blast Bush For Cutting 9/11 Health Plan
- Stryker Yanks Hip Implants After FDA Scolding
- Manufacturer Expands Contaminated Syringe Recall
- Judge May Oust 426 Plaintiffs From Baycol MDL
- Novartis, Dr. Reddy's Deal Ends Exelon MDL
- Wyeth, Teva Persevere In Talks On Protonix Generic
- Retractable's Antitrust, Patent Claims Severed
- Judge Lays Out Prempro Case Timetable
- Just Ahead Of Patent Hearing, TVS Files For Ch. 11
- EU Pharma Probe Expected To Veer From FTC Course
- Ranbaxy Settles With GSK Over Generic Migraine Drug
- Pfizer Updates Chantix Label To Cite Possible Risks
- Eye Surgery Co., Sales Reps Settle Trade Secrets Row
- FDA Aims To Bolster Oversight Of Drug Safety Data
- AstraZeneca Sues To Block Generic Nexium
- High Court Agrees To Hear Wyeth Drug-Labeling Case
- Sanofi Loses Bid To Dismiss Claims Over Arava
- Effects Of China-U.S. Safety Pact On U.S. Companies
- Amgen Under Scrutiny Over Enbrel Marketing
- Bill Would Require That Health Plans Cover Autism
- Judge Grants 30-Day Stay To Negotiating Pharma Cos.
- Patent-Granting System Awaits Serious Shake-Up
- EC Raids Spike Plaintiffs' Interests, But No Suits Yet
- FDA Issues Stiff Warning On Child Cold Medicine
- 1st Circ. Won't Hear CytoLogix's Patent Claims
- Hep C Test Injunction Against Abbott Reversed
- Patent Act Won't Meet "Efficiency" Goals: Sources
- Antidepressant Makers Under Fire For Hiding Data
- FDA's CBE Codification Could Help Defendants
- Summary Judgment Denied In Applera Patent Saga
- Senate Bill May Do Damage to Damages: Sources
- FDA Proposes Stricter Rules On Drug Label Changes
- CryoCor Launches Two Cardiac Device Patent Suits
- Will The New EPA Rule Improve Hospital Air Quality?
- Impax Seeks To Pop Pimple-Fighting Patent
- Device Debris Left In Patients Poses Peril: FDA
- Stryker Wins Dismissal Of Squeaky Hip Implant Case
- Vytorin And Zetia Draw Suits And Scrutiny
- FDA Shakes Head At Stryker's Plant Practices
- Wyeth Fails In Bid To Dismiss Prempro Claim
- Merck Bullish On Vioxx Deal As Deadline Passes
- No Gain For Pain Of Wrongful Death: N.J. Governor
- AWP Plaintiffs Appeal Disqualification Of Counsel
- Diomed Denied Bid To Hold Cos. In Contempt
- As Special Master, She Sets Precedent
- Top Drugmakers Caught In EU Antitrust Raids
- Schering-Plough Settlement OK'd, Lawyers Get $9.5M
- The OIG's Opinion On Warehouse Club Programs
- Federal Preemption Upheld In Heart Valve Case
- Patent Reform Inches Closer To Passage
- Justices Weigh Whether To Hear Preemption Case
- Freedom Of Speech, PDIIs: A Recent Ruling In Maine
- Pfizer And Plaintiffs Fight Over Experts In Viagra Case
- Plea To Leapfrog FDA's Drug Rules Denied Cert
- High-Volume Patent Procurement May Cost More
- Federal Circuit Delivers Blow To Tranquil
- Thimerosal Testimony Barred In Wyeth Vaccine Case
- Pfizer Suffers Setback In Lipitor Patent Re-Exam
- Antitrust Claims Dismissed From HPV Patent Suit
- CMS's Question: To Revise Or Not To Revise
- Merck Inks Deal For Generic Fosamax: Report
- Usana Cleared By SEC, Still Faces Shareholder Suits
- Novartis, 2 Drug Cos. Strike Deal On Trileptal Patent
- Eli Lilly Resumes Gemzar Patent Claim Against Mayne
- Ex-Pfizer Director Granted Bail In Nigeria Drug Case
- Aetna Sues Express Scripts For Return Of $75M
- Calif. Justices, Eyeing Leave Act, Lean Toward Boss
- Celebrex Plaintiffs Suffer Blow In Evidence Spat
- City Scores In Employer-Funded Health Care Battle
- Pfizer Wins Dismissal Of Lipitor Class Action
- Court Refuses To Toss Enzo Shareholder Suit
- Boston Scientific Settles Merger Fight
- Sales Reps Target Solvay With Wage-And-Hour Suit
- Affymetrix, Illumina Strike $90M Settlement Pact
- Judge Nixes Proposed Class Action Against Roche
- N.J. Awaits Governor's OK On Wrongful Death Suit Bill
- Patent Litigator Healey Joins Kenyon & Kenyon LLP
- Foreign Investor Leads Class Action V. Drug Co.
- Medtronic Trade Secrets Suit Back In State Court
- Teva Drops Patent Suit Against Taro Over Heart Drug
- In Employment, Peer Review Privilege Is Not Absolute
- FDA Targets Pharmacies' Hormone Drug Marketing
- Pharmacies May Tread On FDA Turf With HRTs
- Bayer Must Answer Schering Stockholder Query: Court
- Lawmakers Leery Of Heart Doc's TV Plug For Lipitor
- Calif. Study Fails To Find Autism-Vaccine Link
- Growing "Cosmeceutical" Industry Faces Liability
- Judge Finds Purdue's OxyContin Patents Enforceable
- King, CorePharma Settle Skelaxin Suit
- Bristol-Myers Again Rebuffs Plavix Fraud Claims
- TV Ads Minimize Drug Risks: Study
- Applied Medical In-House Counsel Joins Crowell
- Appeals Win, But Maybe Not Cash, For Cordis
- Jan Marini Discontinues Second Eyelash Product
- American Medical Systems Owes $13.8M, Loses CEO
- Court To Reconsider Post-Claim Underwriting Class
- J&J Insists Manufacturer Infringed Neosporin Mark
- CMS Changes Will Curb Profits For Pod, Condo Labs
- Attys Gripe At Vioxx Deal's All-Or-Nobody Provision
- More Evidence Of Anemia Drug Risk: FDA
- Appeals Court Upholds $16M Judgment Against Q-Ray
- Plaintiffs' Attorney Kicked Off AWP Case
- Encysive, Glaxo Target Barr For Blood Clotting Generic
- Hogan & Hartson Adds Partner To Pharma Practice
- Merck Scores As Judge Spurns New Fosamax Class
- Pfizer Loses Lipitor Dispute In Canadian Court
- FDA May Pay Foes' Lawyers In Transplant Dispute
- EEOC Rule On Medicare Stirs Controversy
- Suit Says Sanofi Held Back Info On Obesity Drug
- Activists Sue FDA For Black Box Antibiotic Warnings
- Kinetic Group Sucked Into Suit Over Vacuum Device
- Coughlin Stoia Cashes In On Cardinal Case
- AstraZeneca Slams Seroquel Special Master's Report
- Medtronic Divvies Up $114M To Wind Down Suits
- AstraZeneca Sues Mylan Over Crestor Patent
- Judge Throws UnitedHealth Deal Into Jeopardy
- Drug Giants Probed Over U.N. Oil-For-Food Kickbacks
- Tyco Fires Back In Containers Case
- Judge Seeks Zyprexa Litigation Cleanup